Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Distinct Clinical Syndromes Are Defined by ADAMTS13 Activity in Idiopathic TTP: Results of the SERF-TTP Study.

Anaadriana Zakarija, MD, Hau C. Kwaan, MD PhD, Nicholas Banderanko, MD, Dilip K. Pandey, MD PhD, John F. Cursio, MS, Ivy M. Weiss, BA, Thanh Ha Luu, BA, Jeffrey L. Winters, MD, Thomas L. Ortel, MD PhD, Thomas J. Raife, MD, Ravindra Sarode, MD, Charles L. Bennett, MD PhD MPP

Blood (2007) 110 (11): 1320.

https://doi.org/10.1182/blood.V110.11.1320.1320

Published: 2007

Journal Articles

Clinical and Outcomes Findings for Thrombotic Thrombocytopenic Purpura among 467 Persons with Severely Versus Not Severely Deficient ADAMTS-13 Levels.

Charles L. Bennett, MD, PhD, MPP, Thanh Ha Luu, BA, Anaadriana Zakarija, MD, Hau C. Kwaan, MD, PhD, Nicholas Bandarenko, MD, Dilip K. Pandey, MBBS, MS, PhD, John F. Cursio, MS, June M. McKoy, MD, JD, MPH, Charlie Buffie, BA, Jeffrey L. Winters, MD, Thomas L. Ortel, MD, Ravindra Sarode, MD, X. Long Zheng, MD, PhD, Thomas J. Raife, MD, Masanori Matsumoto, MD, PhD, Yoshihiro Fujimura, MD, PhD, Gail A. Rock, MD, PhD

Blood (2007) 110 (11): 2088.

https://doi.org/10.1182/blood.V110.11.2088.2088

Published: 2007

Journal Articles

Ticlopidine- and Clopidogrel-Associated Thrombotic Thrombocytopenic Purpura (TTP): Final Results from the Surveillance Epidemiology and Risk Factor-TTP Study Group.

Elizabeth A. Richey, BA, Charles L. Bennett, MD, PhD, MPP, Hau C. Kwaan, MD, PhD, Anaadriana Zakarija, MD, MSCI, Nicholas Banderanko, MD, Dilip K. Pandey, MD, PhD, June M. McKoy, MD, JD, MPH, Paul R. Yarnold, PhD, Dennis W. Raisch, PhD, Jeffrey L. Winters, MD, Thomas J. Raife, MD, John F. Cursio, MS, Matthew J. Fisher, Thomas L. Ortel, MD, PhD, Martin S. Tallman, MD, Masanori Matsumoto, MD, PhD, Yoshihiro Fujimura, MD, PhD, Joel L. Moake, MD

Blood (2007) 110 (11): 2089.

https://doi.org/10.1182/blood.V110.11.2089.2089

Published: 2007

Journal Articles

Prognostic Indicators in Severely ADAMTS13 Deficient TMA Patients.

Yasuko O. Erickson, MD, Noelle I. Samia, PhD, Bruce Bedell, BS, Thomas J. Raife, MD

Blood (2006) 108 (11): 3989.

https://doi.org/10.1182/blood.V108.11.3989.3989

Published: 2006

Journal Articles

Targeted Replacement of the Murine Thrombomodulin Gene with Human Thrombomodulin Coding Sequence Results in Decreased Protein C Activation and Enhanced Thrombotic Response to Photochemical Injury.

Thomas J. Raife, MD, Rochelle A. Erger, Katina M. Wilson, Jose A. Fernandez, MD, PhD, Jennifer Alternburg, Hyung-Suk Kim, John H. Griffin, PhD, Nobuyo Maeda, PhD, Steven R. Lentz, MD, PhD

Blood (2004) 104 (11): 2980.

https://doi.org/10.1182/blood.V104.11.2980.2980

Published: 2004

NARROW

Distinct Clinical Syndromes Are Defined by ADAMTS13 Activity in Idiopathic TTP: Results of the SERF-TTP Study.

Clinical and Outcomes Findings for Thrombotic Thrombocytopenic Purpura among 467 Persons with Severely Versus Not Severely Deficient ADAMTS-13 Levels.

Ticlopidine- and Clopidogrel-Associated Thrombotic Thrombocytopenic Purpura (TTP): Final Results from the Surveillance Epidemiology and Risk Factor-TTP Study Group.

Prognostic Indicators in Severely ADAMTS13 Deficient TMA Patients.

Targeted Replacement of the Murine Thrombomodulin Gene with Human Thrombomodulin Coding Sequence Results in Decreased Protein C Activation and Enhanced Thrombotic Response to Photochemical Injury.

Email alerts

ASH Publications

American Society of Hematology

Distinct Clinical Syndromes Are Defined by ADAMTS13 Activity in Idiopathic TTP: Results of the SERF-TTP Study.

Clinical and Outcomes Findings for Thrombotic Thrombocytopenic Purpura among 467 Persons with Severely Versus Not Severely Deficient ADAMTS-13 Levels.

Ticlopidine- and Clopidogrel-Associated Thrombotic Thrombocytopenic Purpura (TTP): Final Results from the Surveillance Epidemiology and Risk Factor-TTP Study Group.

Prognostic Indicators in Severely ADAMTS13 Deficient TMA Patients.

Targeted Replacement of the Murine Thrombomodulin Gene with Human Thrombomodulin Coding Sequence Results in Decreased Protein C Activation and Enhanced Thrombotic Response to Photochemical Injury.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only